Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Fatemeh Mokhtari, Bahareh Bahrami, Gita Faghihi, Ali Asilian & Fariba Iraji. (2022) Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial. Journal of Dermatological Treatment 33:5, pages 2475-2481.
Read now
Read now
Punyaphat Sirithanabadeekul & Rattima Srieakpanit. (2018) Intradermal tranexamic acid injections to prevent post-inflammatory hyperpigmentation after solar lentigo removal with a Q-switched 532-nm Nd:YAG laser. Journal of Cosmetic and Laser Therapy 20:7-8, pages 398-404.
Read now
Read now
Nasrin Saki, Mohammad Darayesh & Alireza Heiran. (2018) Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial. Journal of Dermatological Treatment 29:4, pages 405-410.
Read now
Read now
Jong Yoon Chung, Jong Hee Lee & Joo Heung Lee. (2016) Topical tranexamic acid as an adjuvant treatment in melasma: Side-by-side comparison clinical study. Journal of Dermatological Treatment 27:4, pages 373-377.
Read now
Read now
Articles from other publishers (63)
Zou Jia, Kai Tian, Yuanyuan Zhong, Xiaoyun Wang, Suyue Gao, Wushuang Xu, Ke Li & Lijun Wu. (2023) Effectiveness of combination therapy of broadband light and intradermal injection of tranexamic acid in the treatment of chloasma. Journal of Cosmetic Dermatology 22:5, pages 1536-1544.
Crossref
Crossref
Katelyn M. Kim & Henry W. Lim. (2022) The uses of tranexamic acid in dermatology: a review. International Journal of Dermatology 62:5, pages 589-598.
Crossref
Crossref
Rongxin Ren, Shiwei Bao, Wenjiang Qian & Hongyi Zhao. (2023) Efficacy and Safety of Picosecond Laser in the Treatment of Melasma: A Network Meta-analysis. Dermatologic Surgery 49:5S, pages S49-S55.
Crossref
Crossref
Taylor A. Bullock & Shilpi Khetarpal. (2023) Use of Tranexamic Acid for Melasma. Advances in Cosmetic Surgery 6:1, pages 43-52.
Crossref
Crossref
Jiangfeng Feng, Sihao Shen, Xiuzu Song & Wenzhong Xiang. (2023) Is Tranexamic Acid Use Effective in Preventing Postinflammatory Hyperpigmentation after Laser Treatment? A Systematic Review and Meta-Analysis. Dermatologic Therapy 2023, pages 1-10.
Crossref
Crossref
Jiangfeng Feng, Sihao Shen, Xiuzu Song & Wenzhong Xiang. (2023) Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis. Lasers in Medical Science 38:1.
Crossref
Crossref
Ying Li, Wei‐Na Shao, Qing‐Qing Fang, Wan‐yi Zhao, Shi‐qin Wang, Li‐Hong Wu, Yan‐Yan Hu, Xiao‐feng Wang, Ya‐Nan Xue, Li Chen & Wei‐Qiang Tan. (2022) A combination treatment of drug‐laser‐photon for melasma: A retrospective study of clinical cases. Journal of Cosmetic Dermatology 22:3, pages 822-830.
Crossref
Crossref
Dayoung Ko, Rebecca F. Wang, David Ozog, Henry W. Lim & Tasneem F. Mohammad. (2023) Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation. Journal of the American Academy of Dermatology 88:2, pages 291-320.
Crossref
Crossref
Kazuhisa Maeda. (2022) Mechanism of Action of Topical Tranexamic Acid in the Treatment of Melasma and Sun-Induced Skin Hyperpigmentation. Cosmetics 9:5, pages 108.
Crossref
Crossref
Vikram K. Mahajan, Anant Patil, Leszek Blicharz, Martin Kassir, Nellie Konnikov, Michael H. Gold, Mitchel P. Goldman, Hassan Galadari & Mohamad Goldust. (2022) Medical therapies for melasma. Journal of Cosmetic Dermatology 21:9, pages 3707-3728.
Crossref
Crossref
Wei-Jen Wang, Tai-Yin Wu, Yu-Kang Tu, Kuan-Liang Kuo, Ching-Yao TsaiWei-Chu Chie. (2022) The optimal dose of oral tranexamic acid in melasma: A network meta-analysis. Indian Journal of Dermatology, Venereology and Leprology 89, pages 189-194.
Crossref
Crossref
Shigref Mushtaq, Syeda Sibgha Naz, Muhammad Rizwan, Nudrat Jehangir Khan, Obed Ullah & Anjum Muhammad. (2022) Comparison of the Efficacy of Intralesional Tranexamic Acid Versus Topical 4% Hydroquinone in Treating Melasma. Cureus.
Crossref
Crossref
Yağmur Polat & Gülbahar Saraç. (2022) Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment. Dermatologic Therapy 35:7.
Crossref
Crossref
Aysenur Botsali, Pelin Esme, Hakan Erbil & Ercan Caliskan. (2022) Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma. Lasers in Medical Science 37:7, pages 2823-2830.
Crossref
Crossref
Serena J. E. Shimshak, Leila M. Tolaymat, Claire B. Haga, Nancy L. Dawson, Mindy S. Gillis, Mingyuan Yin, Brandon Kirsch, Maria Cooper & Jason C. Sluzevich. (2021) A Review of Oral Therapies for the Treatment of Skin Hyperpigmentation. Journal of Cutaneous Medicine and Surgery 26:2, pages 169-175.
Crossref
Crossref
Jing PanJing-Hui ZhaoYan-Wei LvShu-Wen ZengJun-Ying ZhaoFeng-Lin Gao. (2022) Clinical Study of a Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser with Different Parameters in the Treatment of Chloasma: A Randomized-Controlled Trial. Photobiomodulation, Photomedicine, and Laser Surgery 40:3, pages 183-188.
Crossref
Crossref
Abdelaal M. Elkamshoushi, Doaa Romisy & Salma S. Omar. (2021) Oral tranexamic acid, hydroquinone 4% and low‐fluence 1064 nm Q‐switched Nd:YAG laser for mixed melasma: Clinical and dermoscopic evaluation. Journal of Cosmetic Dermatology 21:2, pages 657-668.
Crossref
Crossref
Avni Nautiyal & Sarika Wairkar. (2021) Management of hyperpigmentation: Current treatments and emerging therapies. Pigment Cell & Melanoma Research 34:6, pages 1000-1014.
Crossref
Crossref
Shruti Appannavar, Rohith & Gajanan Pise. (2021) Efficacy of oral tranexamic acid versus triple combination for the treatment of melasma: A prospective, double blinded randomised controlled trial. IP Indian Journal of Clinical and Experimental Dermatology 7:3, pages 222-227.
Crossref
Crossref
Adriana Solange Maddaleno, Judit Camargo, Montserrat Mitjans & Maria Pilar Vinardell. (2021) Melanogenesis and Melasma Treatment. Cosmetics 8:3, pages 82.
Crossref
Crossref
Aya Y. Badran, Ahmed U. Ali & Ahmed S. Gomaa. (2021) Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial. Australasian Journal of Dermatology 62:3.
Crossref
Crossref
Behzad Iranmanesh, Maryam Khalili, Saman Mohammadi, Rezvan Amiri & Mahin Aflatoonian. (2021) The efficacy of energy‐based devices combination therapy for melasma. Dermatologic Therapy 34:3.
Crossref
Crossref
Bhumika Chowdhary, Vikram K. Mahajan, Karaninder S. Mehta, Pushpinder S. Chauhan, Vikas Sharma, Anuj Sharma, Sanket Vashist & Prabal Kumar. (2020) Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study. Archives of Dermatological Research 313:2, pages 109-117.
Crossref
Crossref
Khadiga S. Sayed, Samar Tuqan & Rana F. Hilal. (2020) Q‐Switched Nd:YAG (532 nm) Laser Versus Intra‐Dermal Tranexamic Acid for Treatment of Facial Ephelides: A Split Face, Randomized, Comparative Trial. Lasers in Surgery and Medicine 53:3, pages 324-332.
Crossref
Crossref
Yu.I. Vashkevich & V.V. Krumkachou. (2021) Analysis of the use of tranexamic acid for the treatment of melasma. Klinicheskaya dermatologiya i venerologiya 20:1, pages 157.
Crossref
Crossref
Shymaa Hatem, Nada M. El Hoffy, Reham S. Elezaby, Maha Nasr, Amany O. Kamel & Seham A. Elkheshen. (2020) Background and different treatment modalities for melasma: Conventional and nanotechnology-based approaches. Journal of Drug Delivery Science and Technology 60, pages 101984.
Crossref
Crossref
Simin Shamsi Meymandi, Amirhossein Mozayyeni, Manzumeh Shamsi Meymandi & Mahin Aflatoonian. (2020) Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: A single‐blind randomized clinical trial. Journal of Cosmetic Dermatology 19:11, pages 2906-2911.
Crossref
Crossref
K. Minni & S. Poojary. (2020) Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single‐centre, triple‐blind, randomized, placebo‐control, parallel group study. Journal of the European Academy of Dermatology and Venereology 34:11, pages 2636-2644.
Crossref
Crossref
Mirella Batory, Emilia Wołowiec‐Korecka & Helena Rotsztejn. (2020)
The influence of topical
5%
tranexamic acid at pH
2.38
with and without corundum microdermabrasion on pigmentation and skin surface lipids
. Dermatologic Therapy 33:6.
Crossref
Crossref
Pooja J. Sahu, Adarsh Lata Singh, Sandeep Kulkarni, Bhushan Madke, Vikrant Saoji & Sugat Jawade. (2020) Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma. Journal of Cosmetic Dermatology 19:6, pages 1456-1462.
Crossref
Crossref
Rashmi Sarkar, Anuva Bansal & Pallavi Ailawadi. (2020) Future therapies in melasma: What lies ahead?. Indian Journal of Dermatology, Venereology and Leprology 86:1, pages 8.
Crossref
Crossref
Reza Yaghoobi, Samin Vala, Nader Pazyar, Maryam Zeinali & Saeed Hesam. (2019) Comparing Efficacy and Safety of Oral Tranexamic Acid and 4% Topical Hydroquinone Cream in Melasma Treatment: A Randomized Controlled Clinical Trial and Review of Literature. Serbian Journal of Dermatology and Venereology 11:4, pages 119-128.
Crossref
Crossref
Raheel Zubair, Alexis B. Lyons, Gautham Vellaichamy, Anjelica Peacock & Iltefat Hamzavi. (2019) What’s New in Pigmentary Disorders. Dermatologic Clinics 37:2, pages 175-181.
Crossref
Crossref
Aditi Bansal & VidyadharR Sardesai. (2019) Comparison of effectiveness of oral tranexamic acid with that of the topical modified Kligman's formula in the treatment of melasma. Indian Journal of Drugs in Dermatology 5:2, pages 99.
Crossref
Crossref
Margit L. W. Juhasz & Melissa K. Levin. (2018) The role of systemic treatments for skin lightening. Journal of Cosmetic Dermatology 17:6, pages 1144-1157.
Crossref
Crossref
Lei Zhang, Wei-Qiang Tan, Qing-Qing Fang, Wan-Yi Zhao, Qi-Ming Zhao, Jie Gao & Xiao-Wei Wang. (2018) Tranexamic Acid for Adults with Melasma: A Systematic Review and Meta-Analysis. BioMed Research International 2018, pages 1-13.
Crossref
Crossref
Arwa M. Hassan, Ghada F.R. Hassan, Mayada A.F. Ismail & Gamal M. El-Maghraby. (2018) A comparative study between two topical treatments (tranexamic acid and flutamide) in the treatment of patients with melasma. Journal of the Egyptian Womenʼs Dermatologic Society 15:3, pages 144-150.
Crossref
Crossref
Motoko Nakata. (2018) Treatment of Melasma with Low Fluence Q-switched Alexandrite Laser肝斑に対する低フルエンス照射：755 nmナノ秒レーザー. Nippon Laser Igakkaishi 39:2, pages 126-130.
Crossref
Crossref
Harini R. BalaSenhong LeeCelestine WongAmit.G. PandyaMichelle Rodrigues. (2018) Oral Tranexamic Acid for the Treatment of Melasma: A Review. Dermatologic Surgery 44:6, pages 814-825.
Crossref
Crossref
Priyadarshani Galappatthy & Deepani Rathnayake. 2018. Pigmentary Skin Disorders. Pigmentary Skin Disorders
261
280
.
R. Sharma, V. K. Mahajan, K. S. Mehta, P. S. Chauhan, R. Rawat & T. N. Shiny. (2017) Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clinical and Experimental Dermatology 42:7, pages 728-734.
Crossref
Crossref
Linghong Linda Zhou & Akerke Baibergenova. (2017) Melasma: systematic review of the systemic treatments. International Journal of Dermatology 56:9, pages 902-908.
Crossref
Crossref
Eduarda M.P. Silva, Luísa Barreiros, Paula Sá, Carlos Afonso, Sibylle Kozek-Langenecker & Marcela A. Segundo. (2017) Analytical methods for quantification of tranexamic acid in biological fluids: A review. Microchemical Journal 134, pages 333-342.
Crossref
Crossref
Aaron Wei Min Tan, Priya Sen, Sze Hon Chua & Boon Kee Goh. (2017) Oral tranexamic acid lightens refractory melasma. Australasian Journal of Dermatology 58:3, pages e105-e108.
Crossref
Crossref
Vahideh Lajevardi, Afsaneh Ghayoumi, Robabeh Abedini, Hamed Hosseini, Azadeh Goodarzi, Zahra Akbari & Kosar Hedayat. (2017) Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a shor. Journal of Cosmetic Dermatology 16:2, pages 235-242.
Crossref
Crossref
Marina Perper, Ariel Eva Eber, Rachel Fayne, Sebastian Hugo Verne, Robert James Magno, Jessica Cervantes, Mana ALharbi, Ibrahim ALOmair, Abdulkarem Alfuraih & Keyvan Nouri. (2017) Tranexamic Acid in the Treatment of Melasma: A Review of the Literature. American Journal of Clinical Dermatology 18:3, pages 373-381.
Crossref
Crossref
Mohammad Taraz, Somayeh Niknam & Amir Houshang Ehsani. (2017) Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies. Dermatologic Therapy 30:3, pages e12465.
Crossref
Crossref
Nada Elbuluk & Pearl E. Grimes. 2017. Melasma and Vitiligo in Brown Skin. Melasma and Vitiligo in Brown Skin
361
377
.
Maria Suzanne L. Datuin. 2017. Melasma and Vitiligo in Brown Skin. Melasma and Vitiligo in Brown Skin
159
167
.
Ana Carolina Handel, Luciane Donida Bartoli Miot & Hélio Amante Miot. 2017. Daily Routine in Cosmetic Dermatology. Daily Routine in Cosmetic Dermatology
1
14
.
Sandra Maria Barbosa Durães, Rosa Rabello Fonseca & Maria Claudia Almeida Issa. 2017. Daily Routine in Cosmetic Dermatology. Daily Routine in Cosmetic Dermatology
67
99
.
Ana Carolina Handel, Luciane Donida Bartoli Miot & Hélio Amante Miot. 2017. Daily Routine in Cosmetic Dermatology. Daily Routine in Cosmetic Dermatology
419
432
.
Hwee Chyen Lee, Tien Guan Steven Thng & Chee Leok Goh. (2016) Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis. Journal of the American Academy of Dermatology 75:2, pages 385-392.
Crossref
Crossref
H. L. Zhou, B. Hu & C. Zhang. (2016) Efficacy of 694-nm fractional Q-switched ruby laser (QSRL) combined with sonophoresis on levorotatory vitamin C for treatment of melasma in Chinese patients. Lasers in Medical Science 31:5, pages 991-995.
Crossref
Crossref
Young Woon Park & Un Cheol Yeo. (2016) Current and New Strategies for Managing Non-Responders to Laser Toning in the Treatment of Melasma. Medical Lasers 5:1, pages 7-16.
Crossref
Crossref
Hsin-Tung Lin, Gwo-Shing Chen, Feng-Lin Yen & Kuan-Nien Chen. (2016) Objective and Self-Perceived Facial Skin Status Using Whitening Efficacy of Cosmetic Products on Taiwanese Women. Journal of Cosmetics, Dermatological Sciences and Applications 06:04, pages 117-123.
Crossref
Crossref
Sandra Maria Barbosa Durães, Rosa Rabello Fonseca & Maria Claudia Almeida Issa. 2016. Daily Routine in Cosmetic Dermatology. Daily Routine in Cosmetic Dermatology
1
34
.
Ana Carolina Handel, Luciane Donida Bartoli Miot & Hélio Amante Miot. 2016. Daily Routine in Cosmetic Dermatology. Daily Routine in Cosmetic Dermatology
1
14
.
Ai-Young Lee. (2015) Recent progress in melasma pathogenesis. Pigment Cell & Melanoma Research 28:6, pages 648-660.
Crossref
Crossref
Michelle Rodrigues & Amit G Pandya. (2015) Melasma: clinical diagnosis and management options. Australasian Journal of Dermatology 56:3, pages 151-163.
Crossref
Crossref
Sabrina G. Fabi, Daniel P. Friedmann, Ane B. Niwa Massaki & Mitchel P. Goldman. (2014) A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Lasers in Surgery and Medicine 46:7, pages 531-537.
Crossref
Crossref
Tania Ferreira Cestari, Lia Pinheiro Dantas & Juliana Catucci Boza. (2014) Acquired hyperpigmentations. Anais Brasileiros de Dermatologia 89:1, pages 11-25.
Crossref
Crossref
Tsz Wah Tse & Edith Hui. (2013) Tranexamic acid: an important adjuvant in the treatment of melasma. Journal of Cosmetic Dermatology 12:1, pages 57-66.
Crossref
Crossref